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Abstract
Background: Use of conservative treatment modalities in osteoarthritis (OA) is suboptimal, which appears to be
partly due to patients’ beliefs about treatments. The aim of this study was to develop a research instrument
assessing patients’ beliefs about various treatment modalities of hip and knee OA: the ‘Treatment beliefs in OA
(TOA) questionnaire’.
Methods: The item pool that was retrieved from interviews with patients and healthcare providers comprised
beliefs regarding five treatment modalities: physical activity, pain medication, physiotherapy, injections and
arthroplasty. After an extensive selection procedure, a draft questionnaire with 200 items was constructed.
Descriptive analyses and exploratory factor analyses with oblique rotation were conducted for each treatment
modality separately to decide upon the final questionnaire. Internal consistency and test-retest reliability were
determined.
Results: The final questionnaire comprised 60 items. It was completed by 351 patients with knee or hip OA. Each
of the five treatment modalities yielded a two factor solution with 37% to 51% explained variance and high face
validity. Factor I included ‘positive treatment beliefs’ and factor II ‘negative treatment beliefs’. Internal consistency
(Cronbach α’s from 0.72 to 0.87) and test-retest reliability (i.e. intraclass correlation coefficient from 0.66–0.88;
standard error of measurement from 0.06–0.11) were satisfactory to good.
Conclusions: The TOA questionnaire is the first questionnaire assessing positive and negative treatment beliefs
regarding five treatment modalities for knee and hip OA. The instrument will help to understand whether and to
what extent treatment beliefs influence treatment choices.
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Background
Osteoarthritis (OA) of the knee and hip causes pain, stiff-
ness and decreased physical functioning [1]. Because OA
cannot be cured, treatment is directed towards the reduc-
tion of symptoms, improvement of quality of life, and
prevention of progression. Treatment options can be
classified into conservative treatment modalities, such as
lifestyle education, pain medication and physiotherapy,
and surgical treatment modalities, such as an arthroplasty
and osteotomy [1].
Several national and international recommendations
and guidelines for the management of hip and knee OA
recommend that patients first are provided with conser-
vative treatment options, and that they are referred to
surgical treatment only when conservative treatment
does not lead to adequate pain relief and functional im-
provement [2–4]. However, in clinical practice, health
care utilisation is suboptimal in terms of underutilisation
of conservative treatment modalities [5–7] and an
increased use of surgical treatment modalities [8]. This
is undesirable because surgery does not always result in
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good outcomes and pain reduction [9, 10] and may lead
to higher health care costs.
Amongst others, a possible pathway to optimise the
imbalanced use of treatment options is through under-
standing patients’ beliefs about treatment modalities of
knee and hip OA [11, 12]. Patients’ beliefs influence
health-related behaviour as postulated by health beliefs
models, such as the Theory of Planned Behaviour [13].
Previous research found that patients’ beliefs about the
efficacy and safety of medication influence both their
decision to take medication and their preference for the
type of medication [14]. Moreover, it has been suggested
that treatment choices can be better predicted when
beliefs about multiple treatment options are assessed, in-
stead of assessing beliefs about a single treatment option
[15]. Therefore, identifying patients’ beliefs about various
treatment modalities of OA may help to increase the
understanding of treatment decisions.
At present, little is known about how and to what
extent patients’ beliefs about treatment modalities of
knee and hip OA influence patients’ treatment choices.
Previous qualitative studies indicate that many consider-
ations such as patients’ beliefs about the effectiveness
and side-effects of the treatment may play a role in their
treatment choice [16–18]. While qualitative studies are
ideal to get an encompassing overview of all possible de-
terminants of treatment choices, a measurement instru-
ment based on self-reports is needed to get insight into
the relative importance of treatment beliefs in the one
patient as compared to the other. Therefore, guided by
the results of these qualitative studies, a self-report in-
strument is needed in order to be able to systematically
assess patients’ beliefs about treatment modalities for
knee and hip OA. This instrument can be used in
research to examine to what extent patients’ treatment
beliefs contribute to the patients’ decision making process,
and ultimately help to understand why conservative treat-
ment modalities are underused in the management of
knee and hip OA.
In the context of knee and hip OA, no questionnaire
is available that comprehensively assesses patients’ be-
liefs about both surgical and conservative treatment
modalities. Existing questionnaires assess fears and
beliefs related to the consequences of knee OA [19]
and expectations about the role of their physician in
the management of knee OA [20]. Existing self-report
instruments about treatment beliefs refer to low back
pain [21], medicines [22] and surgery [15]. Therefore,
the aim of the current study was to develop a ques-
tionnaire to assess patients’ beliefs about treatment
modalities of knee and hip OA: the TOA (Treatment
beliefs in OsteoArthritis) questionnaire, and to examine
its factorial structure, internal consistency and test-retest
reliability.
Methods
Development of item pool
For the development of a first draft of the TOA ques-
tionnaire an elaborated process was undertaken to
generate and select items based on the findings of three
previous studies among patients with knee and hip OA
in the Netherlands. These were two qualitative studies
[17, 23] on treatment beliefs in patients and healthcare
providers and a concept mapping study [24] to define
the most important themes. A total of 2207 statements
reflecting beliefs about treatment modalities of knee or
hip OA (which could be potentially included as items in
the TOA questionnaire) were extracted from the inter-
views. Items were selected from 4 major themes originated
from the concept mapping study: ‘contextual barriers’ (e.g.
the healthcare system), disadvantages (e.g. risks), treat-
ment outcomes (e.g. physical functioning) and ‘outcomes
for personal life’ (e.g. activities of daily living) [24].
The draft TOA questionnaire consisted of five mod-
ules, based on five treatment options recommended in
the ‘stepped care strategy’ for knee and hip OA in the
Netherlands [3]: physical activities, pain medication,
physiotherapy, injections and arthroplasty. We aimed for
a feasible set of approximately 50 items to include in
each module in the draft version of the TOA question-
naire. In a careful and thorough consensus process, as
described previously [24], all 2207 statements about
specific treatment modalities derived from the interviews
were reduced by a project group comprising researchers
and health professionals including medical specialists.
The selection procedure comprised several steps. For
each step, cut-off points were developed to reach a rep-
resentative set of 51 general items (Additional file 1).
Two patient partners assessed this set of 51 items for its
representativeness and comprehensiveness. In the next
step, all 51 items were assessed for its applicability to
each of the 5 treatment modalities. For instance, the
item ‘the treatment may cause an infection’ was applic-
able for the treatment modality injections and arthro-
plasty, but not for physical activity, pain medication and
physiotherapy. If applicable, the item was included in
the module. The final draft version of the TOA ques-
tionnaire comprised 200 items, distributed over 5
modules: physical activities (41 items), pain medication
(37 items), physiotherapy (42 items), injections (41
items) and arthroplasty (39 items). A 5-point Likert scale
with scoring options ranging from 1 to 5 was chosen, la-
belled from ‘disagree’ to ‘agree’ in order to avoid end-
aversion bias (i.e. avoiding absolute statements as ‘com-
pletely disagree’ and ‘completely agree’ to overcome the
reluctance of some people to use extreme categories of a
scale) [25]. The TOA questionnaire was developed in
Dutch. An English translation of the items can be found
in Additional file 2.
Selten et al. BMC Musculoskeletal Disorders  (2017) 18:402 Page 2 of 10
Pilot testing
The draft TOA questionnaire was pilot tested in a step-
wise way. The first draft of the questionnaire was tested
by five researchers and health professionals. Subsequently,
ten patients were recruited via a primary care physiother-
apy practice in the Northern part of the Netherlands.
Besides the clinical diagnosis of knee or hip OA, no other
inclusion criteria were required. Patients were asked to fill
out the questionnaire at home and to make notes if they
thought a question was difficult to understand. Hereafter,
the researcher contacted the patient for a telephone inter-
view. All items of the questionnaire were discussed, using
the probing method for pilot-testing whether the patient
understood the items, whether items were interpreted
according to their intended meaning, and whether the
length of the questionnaire was considered acceptable
[26, 27]. Including patients for the pilot test was
stopped after 10 interviews because no new informa-
tion emerged from interviewing the last two patients
(data saturation). Based on the results of the pilot
test, minor alterations were made in the instructions
and lay-out.
Patients and measures
Two different samples were recruited for this study. The
first sample was recruited to examine the factor structure
and internal consistency of the TOA questionnaire; the
second sample was recruited to examine the test-retest
reliability of the TOA questionnaire.
Sample 1: Factor structure and internal consistency
Eligible patients who visited the department of Rheuma-
tology of the Sint Maartenskliniek in 2013–2014 (n = 600,
randomly selected from the electronic patient record sys-
tem) or the department of Orthopaedics in June–August
2015 (n = 240, consecutively), who were clinically diag-
nosed with knee or hip OA, and were aged ≥18 received
an information letter and informed consent form. Assum-
ing a number of 4–10 participants per item and 51 unique
items, a sample size of at least 204 patients was needed to
perform the factor analysis [26]. These patients filled out
the TOA questionnaire once. In addition, demographic
and clinical characteristics were collected: body mass
index (BMI), duration of OA symptoms, affected joint(s),
comorbidities (question 70 from the DUTCH-AIMS2
[28]), treatment use, and the Dutch version of the
Western Ontario and McMaster Universities Arthritis
LK3.1 Index (WOMAC). The WOMAC is a health status
measure assessing the dimensions of pain, stiffness and
function in patients with OA of the hip/knee [29].
Sample 2: Test-retest reliability analysis
Patients were consecutively selected from a larger study
sample with similar eligibility criteria as sample 1. To
determine test-retest reliability by calculating an ICC of
0.8 with a 95% confidence interval ± 0.1 using 2 repeated
measurements, 50 respondents are required [26]. Eligible
patients of the department of Rheumatology of the Sint
Maartenskliniek in 2015–2016 (n = 39) or the depart-
ment of Orthopaedics in September 2015–September
2016 (n = 41) were randomly selected from the elec-
tronic patient record system. Patients were invited to fill
out the final TOA questionnaire twice, with a 2 weeks
interval. The first 50 respondents who sent the question-
naire back were included in the analysis, to keep the
time between the first and second measurement close to
the aimed interval of 2 weeks.
The medical ethical board of the Radboud University
Medical Center, Nijmegen concluded that the Dutch
Medical Research Involving Human Subjects Act did not
apply to this study (protocol number: 2015–1772 for
sample 1 and protocol number 2016–2605 for sample 2).
Statistical analyses
Because the TOA questionnaire comprises five treatment
modalities, we aimed for a brief set of items per treatment
module. Therefore, rigorous item reduction and explora-
tory factor analysis were used to design the final TOA
questionnaire. This was conducted per module in three
consecutive steps: initial item reduction, factor analysis
and further refinement. Furthermore, internal consistency
(Cronbach’s alpha) and the test-retest reliability of the final
TOA questionnaire were examined per module.
Step 1: Initial item reduction
Items were considered to be deleted if: a) missing values
were >15%; b) >50% of patients scored 1 (disagree) or 5
(agree) on an item (floor or ceiling effect); c) skewness
of the item was >1; d) inter-item correlations were >.80
(in this case one of the redundant paired items was
considered for deletion) [25].
Step 2: Factor analysis and internal consistency
Exploratory factor analyses were conducted for each mo-
dality separately to examine the dimensionality of the TOA
questionnaire. First, exploratory factor analysis without ro-
tation was used to determine the initial numbers of factors.
This was determined by two researchers (JV and ES) by
visual inspection of the scree plot, percentages of explained
variance (>5%) and eigenvalues >1 [30]. Thereafter, for
each module exploratory factor analysis with oblique
(direct oblimin) rotation was conducted for 2-factor to 4-
factor solutions. Oblique rotation was chosen because it
allowed the extracted factors to be correlated. To select
the most salient items two criteria were used: only
items with factor loadings ≥0.45 were retained, and
items with cross loadings on more than one factor
within 0.3 of the primary loading were dropped because
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of inadequate discrimination [31]. The final number of
factors per module was determined by the project
group based on factor interpretability and revealed a 2-
factor solution for each module.
Step 3: Further refinement
Guided by the results of a previous concept mapping
study [24], items were further considered for deletion.
Briefly, in this concept mapping study, 36 patients sorted
the 51 items (each item printed on a card) from the TOA
questionnaire into piles with a similar meaning; subse-
quently hierarchical cluster analysis yielded a 15-cluster
solution that was grouped in 4 higher-order categories
and 2 overarching categories. The following additional
rules (set by the project group) were applied for further
item reduction per module:
1. Each factor should contain preferably a maximum of
1 item per cluster
2. If more than 1 item per cluster loaded on the factor,
the item with the highest factor loading was retained
3. If internal consistency of a factor, as assessed with
Cronbach’s alpha, dropped below .70, the item with
the next highest factor loading was retained.
4. If internal consistency of the factor, as assessed with
Cronbach’s alpha, was still < .70, an item with the
next highest factor loading from another cluster was
added.
Lastly, a final two-factor factor analysis with the
remaining items per module was conducted. Cronbach’s
alpha was calculated for each factor, and Pearson’s cor-
relation coefficients were calculated between factor I and
factor II per module.
Test-retest reliability
Because each method to assess test-retest reliability of a
questionnaire has its advantages and disadvantages and
is difficult to interpret without other methods [32],
multiple methods were used to assess the test-retest
reliability of the TOA questionnaire. Test-retest reliabil-
ity was determined by 1) Intraclass correlation coeffi-
cients (ICCs) (two-way mixed effects model, measuring
consistency of individual differences) [33]; 2) Limits of
agreement (LoA); and 3) Standard errors of measure-
ment (SEMs) of the whole model including systematic
differences between repeated measures. Scale scores of
the TOA questionnaire were calculated by summation of
the items for each factor. When a respondent had ≤25%
missing items on a subscale, these missing items were
substituted by the respondent’s mean sum score on the
subscale. When a respondent had >25% missing items
on a subscale, these were taken into account as missing
values in the analysis. Unstandardised scores for each
subscale per module were used for calculating ICCs and
the LoA. For calculating the SEM, standardised scores
were calculated (raw total score of subscale / total items on
subscale). Thus, total scores on each subscale were com-
parable on a scale from 1 to 5. ICCs range from 0 to 1,
whereby 1 reflects perfect reliability. In general, ICCs ≥0.70
are considered acceptable [34]. LoA were calculated with
the following formula: mean difference ± 1.96 x SDdifference.
SEM of the whole model including systematic variation of
repeated measures was calculated for each subscale
with: √(σ2m + σ
2
residual). Where σ
2
m = variance between
the two repeated measures; and σ2residual = variance of
the residual (“error”). A smaller SEM reflects better
test-retest reliability [26].
All analyses were performed using STATA 13.1.
Results
Participants
Sample 1
Of 840 invited patients, 351 filled out the TOA question-
naire and provided informed consent (response rate:
41.8%). Eighty-two patients indicated they did not want to
participate in the study. Some patients provided a reason
for non-participation, e.g.: no knee or hip OA (n = 25),
not wanting to (n = 5), comorbidities (n = 4), not satisfied
about care provided by the hospital (n = 3). Ten patients
who did fill out the questionnaire were excluded because
they did not provide informed consent. Three patients did
not fill out the additional questionnaire assessing demo-
graphic and clinical characteristics but were included in
the factor analysis. Table 1 shows the demographic and
clinical characteristics of the study sample.
Sample 2
Of the 80 patients who were invited to fill out the final
TOA questionnaire twice, 67 patients returned the ques-
tionnaire (response rate: 83.8%). The first 50 respondents
who sent the questionnaire back were included in the
analysis, to keep the time between the first and second
measurement close to the aimed interval of 2 weeks
(Mean time interval = 13 days, SD = 2.5, range = 6–18).
The mean age of sample 2 was 63.8 years (SD = 10.5), and
56% was female.
Step 1: Initial item reduction
Item reduction resulted in dropping 9, 8, 8, 2, and 4
items respectively in modules 1 to 5. Two pairs of items
in module 4 had a correlation of 0.81 and 0.82, but
because the items reflected different contents, none of
the items were deleted.
Step 2: Factor structure and internal consistency
Based on exploratory factor analyses and interpretability,
a two-factor solution for each module was obtained.
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Respectively 8, 12, 16, 18, 14 items were dropped be-
cause of factor loadings ≥0.45 or cross loadings <0.3 in
module 1 to 5 (Additional file 2).
Step 3: Further refinement
After the previous steps of item reduction, a total of 24,
17, 18, 22 and 21 items remained for module 1 to 5
respectively). After the third step of refinement, 13 items
remained for module 1 (physical activities), 12 items for
module 2 (pain medication), 9 items for module 3
(physiotherapy), 12 items for module 4 (injections), and
14 items for module 5 (arthroplasty). After this last
round of item reduction, a final 2-factor factor analysis
with oblique (direct oblimin) rotation was performed for
all modules. The explained percentage of variance per
module ranged from 37% to 51%, Cronbach’s alpha’s of
the final TOA questionnaire ranged from .72 to .87, and
correlations between factors ranged from −.03 to −.51
(Table 2).
Factor interpretation
For each module, the first factor reflected positive beliefs
about the treatment, such as health benefits and per-
ceived advantages (e.g. “I learn to deal with my symp-
toms better by the treatment”). The second factor
reflected negative beliefs about the treatment, such as
treatment risks and disadvantages (e.g. “I think that the
treatment involves risks”). Therefore, for each module,
Factor I was labelled ‘positive treatment beliefs’ and Fac-
tor II was labelled ‘negative treatment beliefs’. For each
subscale in each module of the TOA questionnaire, a
sum score can be calculated whereby a higher sum score
on subscale I reflects more positive treatment beliefs and
a higher sum score on subscale II reflects more negative
treatment beliefs. Scorings on the questions M5Q4 and
M5Q9 should be reversed. Missing item scores on a
subscale are replaced with the mean of the other items;
when more than 25% of the items are missing, the sub-
scale score is not valid.
Table 2 presents the factor loadings, eigenvalues, per-
centages of explained variance, Cronbach’s alpha for
each factor per treatment module, and the correlations
between factors per treatment module.
Test-retest reliability
Table 3 shows 3 different measures of test-retest reliabil-
ity for each subscale of the TOA questionnaire. Consid-
ering the moderate to high ICCs (0.66–0.88) and small
SEM (0.06–0.11) obtained for all subscales, test-retest
reliability of the TOA questionnaire was satisfactory.
Discussion
The TOA questionnaire is the first questionnaire asses-
sing treatment beliefs regarding surgical and conserva-
tive (physical activities, pain medication, physiotherapy,
injections) modalities for knee and hip OA. The TOA
questionnaire comprises five treatment modalities with
each a positive and negative subscale. Each part of the
Table 1 Characteristics of the study sample (N=348a)
Demographic characteristics
Age (years), mean (SD) 62.8 (12.3)
Gender (female), n (%) 217 (63.1)
Married or cohabiting, n (%) 273 (79.4)
Currently employed, n (%)b 145 (44.1)
Education level, n (%)c
Low 62 (18.0)
Middle 175 (50.9)
High 107 (31.1)
Clinical characteristics
Body Mass Index (BMI) (kg/m2), n(%)
Normal weight (BMI <25) 106 (31.0)
Overweight (BMI 25–30) 146 (42.7)
Obese (BMI > 30) 90 (26.3)
Duration of OA symptoms (years), mean (SD)b 11.1 (9.8)
Affected joint(s), n (%)
Hip 82 (24)
Knee 169 (49.5)
Hip and knee 91 (26.5)
Comorbidities, n(%)d
No comorbidities 141 (40.8)
High blood pressure 97 (28.0)
Heart disease 39 (11.2)
Diabetes 27 (7.8)
Lung disease 28 (8)
Other 42 (12)
Previous or current treatments for OA, n (%)d
Pain medication 291 (85.3)
Physiotherapy 234 (68.6)
Injections 133 (39.0)
Surgery 112 (32.8)
WOMACe (Likert scale 0–4), unstandardized
mean (SD), theoretical range
Painb 10.0 (4.5), 0–20
Stiffness 4.5 (2.0), 0–8
Functioning 32.4 (14.8), 0–68
Total (sum score)b 46.7 (20.0), 0–96
a 3 respondents did not fill out these questions
bMissing values > 5%: Currently employed = 6%; Duration of OA
symptoms = 7%; WOMAC subscale pain = 5%, WOMAC total (sum score) = 8%
cLow = no education, primary school, lower vocational education;
Middle = secondary school, middle vocational education; High = higher
vocational education, university
dMore than 1 answer possible
eWestern Ontario and McMaster Universities Arthritis Index. Higher scores
reflect worse pain, stiffness and functioning
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Table 2 Factor loadings, eigenvalues, percentage of explained
variance and Cronbach’s alpha for the final TOA questionnaire
Module 1: Physical activities
Items Factor loadings
M1 = Module 1, Q = Question number
(see Additional file 1)
Factor I Factor II
M1Q32: I learn to deal with my symptoms
better by doing physical activities
.77
M1Q19: I can do household chores better
by doing physical activities
.72
M1Q22: Doing physical activities produces
good results at my age
.71
M1Q33: I can do my job better by doing
physical activities
.70
M1Q39: I can tailor doing physical activities
to my goals
.63
M1Q10: I can postpone surgery by doing
physical activities
.53
M1Q14: I can do physical activities together
with others
.48
M1Q8: The only way to reduce my OA
symptoms is by doing physical activities
.47
M1Q20: I enjoy doing physical activities .45
M1Q24: By doing physical activities I will
overload my knee/hip
.72
M1Q23: I think that doing physical activities
causes pain
.66
M1Q7: I think that doing physical activities
involves risks
.65
M1Q28: I am scared to do physical activities .55
Eigenvalue 4.03 1.06
Percentage of variance 31% 8%
Cronbach’s Alpha .84 .79
Correlation between factors −.51
Module 2: Pain medication
Items Factor loadings
M2 = Module 2, Q = Question number
(see Additional file 1)
Factor I Factor II
M2Q10: I can move more freely by using
painkillers
.80
M2Q18: I can do household chores better
by using painkillers
.76
M2Q2: My quality of life increases by using
painkillers
.74
M2Q20: Using painkillers produces good
results at my age
.73
M2Q9: I can postpone surgery by using painkillers .50
M2Q15: Using painkillers is harmful to my health .70
M2Q6: I think that using painkillers involves risks .67
M2Q11: I think that painkillers have side-effects .64
M2Q28: I think that using painkillers is invasive .52
Table 2 Factor loadings, eigenvalues, percentage of explained
variance and Cronbach’s alpha for the final TOA questionnaire
(Continued)
M2Q25: I am scared to use painkillers .47
M2Q19: I think that using painkillers
leads to habituation
.38
M2Q22: By using painkillers I will overload
my knee/hip
.35
Eigenvalue 2.74 2.00
Percentage of variance 23% 17%
Cronbach’s Alpha .82 .72
Correlation between factors −.14
Module 3: Physiotherapy
Items Factor loadings
M3 = Module 3, Q = Question number
(see Additional file 1)
Factor I Factor II
M3Q23: Doing physiotherapy produces
good results at my age
.86
M3Q20: I can do household chores
better by physiotherapy
.85
M3Q34: I can do my job better by
physiotherapy
.76
M3Q3: My quality of life increases by
physiotherapy
.71
M3Q22: I need to actively get going
with physiotherapy myself
.60
M3Q10: I can postpone surgery by
physiotherapy
.52
M3Q25: By physiotherapy I will overload
my knee/hip
.71
M3Q24: I think that physiotherapy causes pain .70
M3Q7: I think that physiotherapy involves risks .62
Eigenvalue 3.49 1.09
Percentage of variance 39% 12%
Cronbach’s Alpha .86 .74
Correlation between factors −.36
Module 4: Injections
Items Factor loadings
M4 = Module 4, Q = Question number
(see Additional file 1)
Factor I Factor II
M4Q33: I can do my job better by an
injection
.89
M4Q20: I can do household chores better
by an injection
.88
M4Q3: My quality of life increases by an
injection
.76
M4Q30: An injection gives quick results .76
M4Q10: I can postpone surgery by an
injection
.62
M4Q31: I think that an injection can be
repeated
.47
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questionnaire can be used independently, so beliefs
regarding either one or multiple treatment modalities
can be measured. A main strength of this study was the
design used to generate the items. For the selection of
items, we used two previous in-depth interview studies
in which both patients and healthcare providers were
asked about their beliefs and views regarding treatment
modalities for knee and hip OA [17, 23]. The item pool
was generated very carefully in several consensus rounds
by the project team, and selected items were assessed by
patients. As a result, based on the perspective of patients
and professionals, we developed a questionnaire to com-
prehensively assess both positive and negative treatment
beliefs in knee and hip OA. The qualitative approach
will have contributed to the face validity. The internal
consistency and test-retest reliability of the TOA ques-
tionnaire were satisfactory to good. Confirmatory factor
analysis and replication of clinimetric properties in other
samples as well as validation studies such as studies
examining the association with actual treatment choices
are needed in order to fully establish the validity and
reliability of the TOA questionnaire.
The 2-factor structure reflected individual differences in
positive and negative beliefs about treatment modalities.
Similarly to existing generic questionnaires about medica-
tion (Beliefs about Medicines Questionnaire (BMQ) [22])
and surgery (Beliefs about Surgery Questionnaire (BSQ)
[15]), the TOA questionnaire assesses negative treatment
beliefs as a distinct dimension. In contrast to the BMQ
Table 2 Factor loadings, eigenvalues, percentage of explained
variance and Cronbach’s alpha for the final TOA questionnaire
(Continued)
M4Q24: By an injection I will overload
my knee/hip
.62
M4Q15: I am becoming dependent on
an injection
.61
M4Q34: An injection damages my knee/hip .60
M4Q32: I think that an injection is invasive .54
M4Q7: I think that an injection involves risks .48
M4Q40: An injection takes a lot of my time .38
Eigenvalue 3.54 1.78
Percentage of variance 30% 15%
Cronbach’s Alpha .87 .72
Correlation between factors −.11
Module 5: Arthroplasty
Items Factor loadings
M5 = Module 5, Q = Question number
(see Additional file 1)
Factor I Factor II
M5Q4: My pain increases by a joint
replacement
−.61
M5Q9: My knee/hip deteriorates faster
by a joint replacement
−.51
M5Q10: I can move more freely after a
joint replacement
.78
M5Q17: I can do household chores better
after a joint replacement
.77
M5Q18: A joint replacement produces
good results at my age
.81
M5Q21: More people with OA choose to
do a joint replacement
.43
M5Q29: I think that a joint replacement
can be repeated
.45
M5Q38: I think that an artificial joint lasts a
long time
.44
M5Q1: I think a joint replacement is painful .51
M5Q23: I think an artificial joint carries the
chance of an infection
.57
M5Q24: I think a joint replacement carries
the chance of an infection
.67
M5Q27: A joint replacement takes up my
energy
.53
M5Q30: I think that a joint replacement is
invasive
.62
M5Q37: A joint replacement takes a lot of
my time
.60
Eigenvalue 3.13 2.14
Percentage of variance 22% 15%
Cronbach’s Alpha .81 .75
Correlation between factors −.03
Table 3 Intraclass correlation coefficient (ICC), mean difference
between repeated measures, limits of agreement (LoA), and
standard error of measurement (SEM) including systematic
differences between repeated measures and error variance
Module Subscale ICC Mean difference LoA SEM
Physical activity positive
9 items
.88 −.44 −7.65; 6.78 .06
negative
4 items
.74 .81 −4.60; 6.23 .10
Pain medication positive
5 items
.80 .19 −6.44; 6.82 .09
negative
7 items
.83 .59 −6.82; 8.00 .08
Physiotherapy positive
6 items
.88 .16 −6.35; 6.67 .08
negative
3 items
.72 −0.40 −4.81; 4.01 .11
Injections positive
6 items
.88 0.05 −5.85; 5.96 .07
negative
6 items
.83 .45 −5.06; 5.96 .07
Arthroplasty positive
8 items
.66 −.20 −9.14; 8.75 .08
negative
6 items
.77 .45 −5.52; 6.41 .07
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and BSQ, the TOA questionnaire also assesses positive
beliefs about treatment modalities. The small correla-
tions between the factors – especially for the modules
pain medication, injections and arthroplasty – show
that positive and negative beliefs are not the opposite
poles of a single dimension. This indicates the import-
ance of measuring both patients’ negative and positive
treatment beliefs in order to fully understand patients’
treatment preferences.
The TOA questionnaire can primarily be used as a re-
search tool to assess individual differences in treatment
beliefs and to examine to what extent treatment beliefs
influence treatment choices in OA. Previous research
showed that patients with knee or hip OA differ in their
willingness to undergo surgery, and that this difference
might be due to individual differences in sex, ethnicity,
socioeconomic status [35], severity, age and income [36].
In interaction with, and in addition to these sociodemo-
graphic characteristics, treatment beliefs will likely play a
role in treatment choices, specifically in suboptimal use
of conservative treatment modalities. Previous studies
have demonstrated the practice variation in primary care
settings with regard to diagnostic procedures and referrals
[37, 38], and that referrals by the GP to other disciplines
are associated with patients’ preferences [39]. This sug-
gests that besides organisational and healthcare provider-
related factors, patients’ treatment beliefs should be taken
into account, in order to choose a treatment that fits best
to the patient’s individual situation and preferences. In
clinical practice, individual scores at the TOA question-
naire could be used as an input for shared decision mak-
ing. However, users should be aware that the item pool
reflects a restricted number of items that predominantly
reflect individual differences. To get an encompassing
overview of treatment beliefs that may be important for
an individual patient, it is better to use all statements from
a previous concept mapping study [24] which represent a
wide range of potential benefits and barriers.
Some limitations of the study need to be addressed.
Firstly, our findings in a secondary care sample cannot be
generalised to other samples or settings without empirical
replication. With respect to external validity, cross-
cultural validation studies are needed to examine whether
the TOA questionnaire is valid to use in other languages
and cultures than Dutch. Also other aspects of validity
need to be more extensively evaluated, such as construct
validity and criterion validity. In new samples, the struc-
tural validity of the TOA questionnaire could be further
evaluated by using confirmatory factor analyses to verify
whether the factor structure is replicated and Item-
Response Theory to improve the precision of the measure-
ment instrument [26]. On average, our sample reported
moderate OA complaints in terms of pain, stiffness and
functioning [29, 40]. Future research needs to examine the
robustness of the factor structure of the TOA in other
samples. Secondly, the response rate for sample 1 in
this study was 42%, which could indicate a response
bias. The questionnaire was quite long, which might
have been burdensome for patients. The response rate,
however, is comparable to other studies in knee or hip
OA [41]. Moreover, 351 respondents filled in the ques-
tionnaire, which is sufficient for a factor analysis [26].
Thirdly, patients’ involvement in the item reduction
process for the TOA questionnaire was limited to an
assessment of the comprehensiveness and completeness
of the items by two patients and an extensive pilot-test in
10 primary care patients. However, items for the TOA
questionnaire were selected in a careful and thorough
process to enhance the validity of the questionnaire.
Conclusions
The TOA questionnaire assesses positive and negative
treatment beliefs of patients with knee or hip OA about 5
treatment modalities: physical activities, pain medication,
physiotherapy, injections and arthroplasty. Initial analyses
of the clinimetric properties of the TOA questionnaire are
promising. The questionnaire can be used in research to
clarify treatment choices. Future research should assess
the validity and reliability of the TOA questionnaire in
other OA samples, and should verify whether treatment
beliefs in interaction with other variables influence
intended and actual treatment choices.
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